Continuous and intermittent parathyroid hormone administration promotes osteogenic differentiation and activity of programmable cells of monocytic origin

Simple item page
dc.contributor.authorKir, MC
dc.contributor.authorOnal, MO
dc.contributor.authorUluer, ET
dc.contributor.authorUlman, C
dc.contributor.authorInan, S
dc.date.accessioned2024-07-18T12:05:13Z
dc.date.available2024-07-18T12:05:13Z
dc.description.abstractBone healing deficiencies are challenging for orthopedic practice. The use of stem cells with scaffolds to treat bone tissue losses currently is popular for promoting regeneration of tissue. Programmable cells of monocytic origin (PCMO) may differentiate into three germ layers and may be a promising alternative treatment due to their stem cell-like properties. Parathyroid hormone (PTH) participates in bone metabolism. Intermittent administration of PTH promotes osteogenic activity of mesenchymal stem cdells (MSC). We investigated the osteogenic effects of continuous and intermittent administration of PTH on PCMO. Mononuclear cells were harvested from the peripheral blood of healthy donors. Isolated cells were cultured for six days in a de-differentiation medium. Indirect immunocytochemistry using anti-CD14, anti-CD45 and anti-CD90 primary antibodies, as well as electron microscopy were used to detect PCMO. PCMO then were cultured in an osteogenic differentiation medium supplemented with continuous or intermittent 50 ng/ml PTH. The PTH-free control group (CG), intermittent PTH treated group (IPG) and continuous PTH treated group (CPG) were cultured and assessed for their differentiation into osteogenic lineage cells by indirect immunocytochemistry using anti-collagen I, anti-osteonectin and anti-osteocalcin primary antibodies. Osteoblast-like cells obtained by continuous or intermittent PTH administration exhibited increased levels of collagen I, osteonectin and osteocalcin immunoreactivity. We found that continuous and intermittent PTH administration to PCMO enhanced their differentiation to osteogenic lineage cells and increased osteoblastic activity.
dc.identifier.issn1052-0295
dc.identifier.other1473-7760
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/9608
dc.language.isoEnglish
dc.publisherTAYLOR & FRANCIS LTD
dc.subjectMESENCHYMAL STEM-CELLS
dc.subjectINCREASED BONE-FORMATION
dc.subjectPROLIFERATION
dc.subjectEXPRESSION
dc.subjectDEFECTS
dc.titleContinuous and intermittent parathyroid hormone administration promotes osteogenic differentiation and activity of programmable cells of monocytic origin
dc.typeArticle

Files

Collections

Web of Science Koleksiyonu